Rivaroxaban Monotherapy in Patients With Atrial Fibrillation and Coronary Stenting at Multiple Vessels or the Left Main Trunk: The AFIRE Trial Subanalysis.
Mitsuru IshiiMasaharu AkaoSatoshi YasudaKoichi KaikitaJunya AkoTetsuya MatobaMasato NakamuraKatsumi MiyauchiNobuhisa HagiwaraKazuo KimuraAtsushi HirayamaKunihiko MatsuiHisao Ogawanull nullPublished in: Journal of the American Heart Association (2022)